Bijal Parikh, MD, PhD

Assistant Professor, Pathology & Immunology

Additional Titles

  • Medical Director, Molecular Diagnostics Laboratory
  • Associate Medical Director, Molecular Infectious Disease Laboratory
  • Associate Medical Director, HLA Laboratory

Education

  • BS: Rutgers University, New Brunswick, NJ (1998)
  • PhD: Rutgers University, New Brunswick, NJ (2004)
  • MD: Robert Wood Johnson Medical School-Rutgers University, Piscataway, NJ (2006)
  • Residency, Clinical Pathology : Washington University, St. Louis, MO (2010)

Board Certifications

  • Missouri Medical License
  • American Board of Pathology in Clinical Pathology, 2011
  • American Board of Pathology in Molecular Genetic Pathology, 2019

Recognition

  • National Science Foundation Undergraduate Research Grant, 1997- 1998

  • Outstanding Achievement in the MD/PhD Program, UMDNJ-Robert Wood Johnson Medical School, 2006

  • Outstanding Research Award in Molecular Pathology/Pharmacogenomics, American Association for Clinical Chemistry Annual Meeting, 2009

  • Paul E. Strandjord Young Investigator Award, Academy of Clinical Laboratory Physicians and Scientists Annual Meeting, 2009, 2010

  • Infectious Diseases Training Grant (T32-A1007172) (Appointments to this TG are limited to one year.), 2010

  • Rheumatology Training Grant (T32-AR007279), 2011-2012

Research Interests

My basic science interests are focused on understanding the mechanisms governing host-pathogen interactions. Current research projects include the development of a murine cytomegalovirus model study innate immune control by natural killer cells and trafficking of virus during neonatal infection.

Publications

Parikh, B.A., Piersma, S.J., and Yokoyama, W.M., 2016. NK Cells in Antiviral Defense. In: Ratcliffe, M.J.H. (Editor in Chief), Encyclopedia of Immunobiology, Vol. 4, pp. 243–252. Oxford: Academic Press
Parikh BA, Piersma SJ, Pak-Wittel MA, Yang L, Schreiber RD, Yokoyama WM: Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells. PLoS Pathog. 2015 11:e1005323
Parikh, B.A., Beckman, D.L., Patel, S.J., White, J.M., and Yokoyama, W.M. Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing. PLoS One. 2015; 10:e0116484
Leong, J.W., Schneider, S.E., Sullivan, R.P., Parikh, B.A., Anthony, B.A., Singh, A., Jewell, B.A., Schappe, T., Wagner, J.A., Link, D.C., Yokoyama, W.M., and Fehniger, T.A. PTEN regulates natural killer cell trafficking in vivo. PNAS. 2015; 112:E700-9
Memon I., Parikh, B.A., Gaudreault-Keener, M., Skelton, R, Storch, G.A., and Brennan, D.C. Progression from sustained BK-viruria to sustained BK-viremia with immunosuppression reduction is not associated with changes in the noncoding control region of the BK-virus genome. J. Transplant. 2012; 2012:761283. PMCID: PMC3373156
Parikh B.A., Siedlecki AM, and Scott MG. Specificity of a circulating antibody that interferes with a widely used tacrolimus immunoassay. Ther Drug Monit. 2010; 32:228-231. PMID: 20216109

Assistant
Christine Berry
314-362-2207
berryc@wustl.edu
Lab Phone: 314-747-1071
Office Location: LGM, Suite 5806